Apogee Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Apogee Therapeutics by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $952k | 34k | 27.95 |